Bruera Eduardo, Schoeller Teresa, Montejo Gustavo
Palliative Care Program, Edmonton General Hospital, University of Alberta, Edmonton, Alberta T5K 0L4 Canada.
Pain. 1992 Mar;48(3):397-399. doi: 10.1016/0304-3959(92)90090-X.
We report 4 patients who developed organic hallucinosis while receiving opiate analgesics for cancer pain. In all patients, the symptoms rapidly responded to haloperidol and change in the type of opiate. The hallucinations were exclusively visual. Cognitive status, determined by the Mini-mental State Questionnaire (MMSQ), was normal in all patients. Organic hallucinosis occasionally occurs in patients receiving opiates and can be a major source of distress for patients and their families.
我们报告了4例在接受阿片类镇痛药治疗癌痛时出现器质性幻觉症的患者。在所有患者中,症状迅速对氟哌啶醇和阿片类药物类型的改变产生反应。幻觉均为视觉性的。通过简易精神状态检查表(MMSQ)测定,所有患者的认知状态均正常。器质性幻觉症偶尔会出现在接受阿片类药物治疗的患者中,可能成为患者及其家属痛苦的主要来源。